Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, CMG, CFG

Media Advisory - Minister Blair to make a funding announcement to Canadian Non-Governmental Organizations assisting with Emergency Management and Response


OTTAWA, ON, May 3, 2022 /CNW/ - Members of the media are invited to join the Honourable Bill Blair, President of the Queen's Privy Council for Canada and Minister of Emergency Preparedness, for a funding announcement to support both capacity building and domestic deployment to four Canadian emergency management NGOs under the Supporting a Humanitarian Workforce to Respond to COVID-19 and Other Large-Scale Emergencies (HWF) program.

Following the announcement, Minister Blair will take questions from the media.

This event will also be livestreamed via our YouTube channel: Safety in Canada.

Questions will only be possible via teleconference (details included below). Media can also view the news conference via Zoom (registration required as per instructions below).

Date
Wednesday, May 4, 2022

Time
1:00 p.m. EDT

Media who wish to participate by phone can dial-in by using the numbers below. Media are encouraged to dial-in 15 minutes before the start of the news conference. (Only teleconference participants will be able to ask questions).

Participant dial-in numbers: 1-866-805-7923 / 613-960-7518
Access Code: 2392957#

To view the news conference via Zoom (view only and no questions), please send an email to [email protected]. Registrations must be completed no later than 9:00 a.m. (EDT) on Wednesday, May 4.  

SOURCE Public Safety and Emergency Preparedness Canada


These press releases may also interest you

at 02:28
Allied Market Research published a report, titled, "Pet Insurance Market by Policy Coverage (Accident Only, Accident and Illness, and Others), Animal Type (Dogs, Cats, and Others), and Sales Channel (Agency, Broker, and Others): Global...

at 02:00
Bradda Head Lithium Ltd (AIM:BHL), the North America-focused lithium development group, is pleased to announce that it has come to a settlement regarding the fraudulent payment first notified on 29 March 2022 and subsequently disclosed in the audited...

at 00:25
Zai Lab Limited and Innoviva Specialty Therapeutics today announced that China's National Medical Products Administration (NMPA) has approved Zai Lab's New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of...

19 mai 2024
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

19 mai 2024
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...



News published on and distributed by: